FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

407895000: Buprenorphine 35micrograms/hour transdermal patch (product)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    2151725012 Buprenorphine 35micrograms/hour transdermal patch (product) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    2159479018 Buprenorphine 35micrograms/hour transdermal patch en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Buprenorphine 35micrograms/hour transdermal patch Is a Product containing buprenorphine (medicinal product) false Inferred relationship Some
    Buprenorphine 35micrograms/hour transdermal patch The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Opioid receptor partial agonist false Inferred relationship Some
    Buprenorphine 35micrograms/hour transdermal patch The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Buprenorphine (substance) false Inferred relationship Some
    Buprenorphine 35micrograms/hour transdermal patch The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Opiate agonist-antagonist false Inferred relationship Some
    Buprenorphine 35micrograms/hour transdermal patch The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Central nervous system agent (substance) false Inferred relationship Some
    Buprenorphine 35micrograms/hour transdermal patch Has manufactured dose form forme pharmaceutique pour usage transdermique et/ou cutané false Inferred relationship Some
    Buprenorphine 35micrograms/hour transdermal patch Is a Product containing buprenorphine in topical dosage form false Inferred relationship Some
    Inbound Relationships Type Active Source Characteristic Refinability Group

    Reference Sets

    Concept inactivation indicator reference set

    Description inactivation indicator reference set

    GB English

    US English

    POSSIBLY EQUIVALENT TO association reference set (foundation metadata concept)

    Back to Start